Francesco Cuccia1,2, Gianluca Mortellaro3, Lucia Ognibene4, Giuseppe Craparo5, Antonio Lo Casto6, Giuseppe Ferrera3. 1. Radiation Oncology School, University of Palermo, Palermo, Italy f.cuccia1@virgilio.it. 2. Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Verona, Italy. 3. Radiotherapy Unit, ARNAS Civico Hospital, Palermo, Italy. 4. Radiotherapy Unit, San Gaetano Radiotherapy and Nuclear Medicine Center, Palermo, Italy. 5. Neuroradiology Unit, ARNAS Civico Hospital, Palermo, Italy. 6. Radiation Oncology School, University of Palermo - Section of Radiology - Di.Bi.Med., Palermo, Italy.
Abstract
BACKGROUND/AIM: Medulloblastoma is a rare tumor of adult age, while it occurs more frequently in children. Given the rarity, there is a lack of evidence for the treatment of recurrent disease. Few data are available about salvage re-irradiation collecting very heterogeneous series. CASE REPORT: A 51-year-old male presented with headache, nausea, double vision, and gait disorders. A contrast-enhanced brain-MRI showed the presence of multifocal medulloblastoma. After surgery, adjuvant craniospinal radiotherapy was performed, chemotherapy was stopped due to toxicity. After 27 months, a new MRI and a Methionine-PET revealed a late pontocerebellar relapse; multidisciplinary board decided for a SBRT treatment. The second course of RT was well tolerated and 14 months later, the patient is alive in good general conditions, with no evidence of disease. CONCLUSION: Our experience supports the use of salvage stereotactic radiotherapy as a safe and effective treatment option. Copyright
BACKGROUND/AIM: Medulloblastoma is a rare tumor of adult age, while it occurs more frequently in children. Given the rarity, there is a lack of evidence for the treatment of recurrent disease. Few data are available about salvage re-irradiation collecting very heterogeneous series. CASE REPORT: A 51-year-old male presented with headache, nausea, double vision, and gait disorders. A contrast-enhanced brain-MRI showed the presence of multifocal medulloblastoma. After surgery, adjuvant craniospinal radiotherapy was performed, chemotherapy was stopped due to toxicity. After 27 months, a new MRI and a Methionine-PET revealed a late pontocerebellar relapse; multidisciplinary board decided for a SBRT treatment. The second course of RT was well tolerated and 14 months later, the patient is alive in good general conditions, with no evidence of disease. CONCLUSION: Our experience supports the use of salvage stereotactic radiotherapy as a safe and effective treatment option. Copyright
Authors: Ulrich Herrlinger; A Steinbrecher; J Rieger; P Hau; R-D Kortmann; R Meyermann; M Schabet; M Bamberg; J Dichgans; U Bogdahn; M Weller Journal: J Neurol Date: 2005-02-23 Impact factor: 4.849
Authors: Michela Buglione; Paolo Ghirardelli; Luca Triggiani; Sara Pedretti; Nadia Pasinetti; Berardino De Bari; Sandro Tonoli; Paolo Borghetti; Luigi Spiazzi; Stefano Maria Magrini Journal: Rep Pract Oncol Radiother Date: 2015-04-08
Authors: Avani D Rao; Arif S Rashid; Qinyu Chen; Rosangela C Villar; Daria Kobyzeva; Kristina Nilsson; Karin Dieckmann; Alexey Nechesnyuk; Ralph Ermoian; Sara Alcorn; Shannon M MacDonald; Matthew M Ladra; Eric C Ford; Brian A Winey; Maria Luisa S Figueiredo; Michael J Chen; Stephanie A Terezakis Journal: Int J Radiat Oncol Biol Phys Date: 2017-07-29 Impact factor: 7.038
Authors: Dagmar Beier; Martin Proescholdt; Christiane Reinert; Torsten Pietsch; David T W Jones; Stefan M Pfister; Elke Hattingen; Clemens Seidel; Linda Dirven; Ralf Luerding; Jaap Reijneveld; Monika Warmuth-Metz; Matteo Bonsanto; Michael Bremer; Stephanie E Combs; Stefan Rieken; Ulrich Herrlinger; Holger Kuntze; Regine Mayer-Steinacker; Dag Moskopp; Thomas Schneider; Andreas Beringer; Uwe Schlegel; Walter Stummer; Helmut Welker; Astrid Weyerbrock; Frank Paulsen; Stefan Rutkowski; Michael Weller; Wolfgang Wick; Rolf-Dieter Kortmann; Ulrich Bogdahn; Peter Hau Journal: Neuro Oncol Date: 2018-02-19 Impact factor: 12.300